Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
CALL
Syndax Pharmaceuticals
SNDX
$1.76B
| $2.88M | ﹤0.01% |
137,200
+29,600
| +28% | +$516K |
|
5202
Biglari Holdings Class B
BH
$1.24B
| $2.88M | ﹤0.01% |
+8,671
| New | +$2.91M |
|
5203
Harmonic Inc
HLIT
$1.32B
| $2.88M | ﹤0.01% |
291,327
+106,947
| +58% | +$1.08M |
|
5204
PUT
Alliance Resource Partners
ARLP
$3.25B
| $2.88M | ﹤0.01% |
124,000
-65,100
| -34% | -$1.58M |
|
|
NPKI
5205
NPK International
NPKI
$1.16B
| $2.88M | ﹤0.01% |
241,640
-282,039
| -54% | -$3.44M |
|
5206
CALL
Bentley Systems
BSY
$10.8B
| $2.88M | ﹤0.01% |
75,400
-51,000
| -40% | -$2.32M |
|
5207
CALL
Vera Therapeutics
VERA
$2.16B
| $2.88M | ﹤0.01% |
56,800
+41,700
| +276% | +$1.48M |
|
5208
Farmers National Banc Corp
FMNB
$943M
| $2.87M | ﹤0.01% |
+215,812
| New | +$2.95M |
|
5209
PUT
PTC
PTC
$15.2B
| $2.87M | ﹤0.01% |
16,500
+10,200
| +162% | +$1.9M |
|
5210
Aramark
ARMK
$14.9B
| $2.87M | ﹤0.01% |
77,951
-629,656
| -89% | -$24M |
|
|
AVDL
5211
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
| $2.87M | ﹤0.01% |
133,300
-65,400
| -33% | -$1.27M |
|
5212
Bio-Rad Laboratories Class A
BIO
$9.21B
| $2.87M | ﹤0.01% |
9,480
-40,826
| -81% | -$12.7M |
|
5213
PUT
Brighthouse Financial
BHF
$3.58B
| $2.87M | ﹤0.01% |
44,300
-132,900
| -75% | -$7.81M |
|
5214
CALL
AGCO
AGCO
$7.32B
| $2.87M | ﹤0.01% |
27,500
+17,500
| +175% | +$1.86M |
|
|
CEPU
5215
Central Puerto
CEPU
$2.15B
| $2.87M | ﹤0.01% |
163,926
+77,435
| +90% | +$1.07M |
|
5216
Tradeweb Markets
TW
$21.8B
| $2.87M | ﹤0.01% |
26,668
-33,078
| -55% | -$3.55M |
|
5217
Emergent Biosolutions
EBS
$388M
| $2.87M | ﹤0.01% |
232,019
-107,632
| -32% | -$1.15M |
|
5218
PUT
Idaho Strategic Resources
IDR
$519M
| $2.87M | ﹤0.01% |
71,100
-55,800
| -44% | -$2.13M |
|
5219
Procept Biorobotics
PRCT
$1.09B
| $2.86M | ﹤0.01% |
91,061
+54,310
| +148% | +$1.8M |
|
5220
Global X S&P 500 Covered Call ETF
XYLD
$3.27B
| $2.86M | ﹤0.01% |
+70,490
| New | +$2.82M |
|
5221
QuinStreet
QNST
$890M
| $2.86M | ﹤0.01% |
199,138
-17,923
| -8% | -$259K |
|
5222
Vipshop
VIPS
$7.49B
| $2.86M | ﹤0.01% |
161,710
-179,349
| -53% | -$3.45M |
|
5223
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$63.3M
| $2.86M | ﹤0.01% |
+135,779
| New | +$3.68M |
|
5224
CALL
Starwood Property Trust
STWD
$6.01B
| $2.86M | ﹤0.01% |
158,600
-53,500
| -25% | -$984K |
|
5225
CALL
Wendy's
WEN
$1.5B
| $2.86M | ﹤0.01% |
342,800
+139,700
| +69% | +$1.21M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,363 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.